About: Sudipta Saha
- Website
- Details
- Associate Professor at Department of Microbiology and Biotechnology, Sister Nivedita University, Kolkata.
Posts by Sudipta Saha:
-
May 2, 2025 Shaping the Future: The Rise of Structural Nanomedicine
-
May 2, 2025 Resitu Medical Sets Stage for Breakthrough in Breast Tumour Removal
-
March 18, 2025 Unlocking the Secrets of Longevity: A 117-Year-Old Woman’s Genes Defied Aging
-
February 4, 2025 Bridging the Gender Gap in Healthcare: Unlocking Biopharma’s Potential in Women’s Health
-
December 1, 2024 Chicoric Acid: A Natural Boost for Glucose Metabolism via AMPK Activation
-
November 26, 2024 SNU-BioTalk 2025: Symphony of Cellular Signals in Metabolism and Immune Response – International Conference at Sister Nivedita University, Kolkata, India on 16 & 17 January 2025
-
October 24, 2024 Powerful Cancer-Fighting Foods and Their Role in Body Repair
-
October 22, 2024 Xenotransplantation: Pioneering a New Era of Organ Availability
-
September 16, 2024 Immunotherapy with pembrolizumab boosts post-surgical outcomes in high-risk bladder cancer patients
-
September 10, 2024 Armored CD7-CAR T Cells: A Fratricide-Resistant Solution for T-ALL Therapy
Follow Blog via Email
Join 2,041 other subscribers-
Recent Posts
- FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
- Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
- In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
- Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
- AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
- In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
- Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
- 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
- Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI-in-Health, Life Sciences & BioPharma June 15, 2026
- Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026
Archives
Categories
Meta